These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32794080)
1. Formulation Optimization of Selective Laser Sintering 3D-Printed Tablets of Clindamycin Palmitate Hydrochloride by Response Surface Methodology. Mohamed EM; Barakh Ali SF; Rahman Z; Dharani S; Ozkan T; Kuttolamadom MA; Khan MA AAPS PharmSciTech; 2020 Aug; 21(6):232. PubMed ID: 32794080 [TBL] [Abstract][Full Text] [Related]
2. Understanding the effects of formulation and process variables on the printlets quality manufactured by selective laser sintering 3D printing. Barakh Ali SF; Mohamed EM; Ozkan T; Kuttolamadom MA; Khan MA; Asadi A; Rahman Z Int J Pharm; 2019 Oct; 570():118651. PubMed ID: 31493496 [TBL] [Abstract][Full Text] [Related]
3. Very-Rapidly Dissolving Printlets of Isoniazid Manufactured by SLS 3D Printing: In Vitro and In Vivo Characterization. Khuroo T; Mohamed EM; Dharani S; Kayalar C; Ozkan T; Kuttolamadom MA; Rahman Z; Khan MA Mol Pharm; 2022 Aug; 19(8):2937-2949. PubMed ID: 35648147 [TBL] [Abstract][Full Text] [Related]
4. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Fina F; Madla CM; Goyanes A; Zhang J; Gaisford S; Basit AW Int J Pharm; 2018 Apr; 541(1-2):101-107. PubMed ID: 29454028 [TBL] [Abstract][Full Text] [Related]
5. 3D-printing of lopinavir printlets by selective laser sintering and quantification of crystalline fraction by XRPD-chemometric models. Hamed R; Mohamed EM; Rahman Z; Khan MA Int J Pharm; 2021 Jan; 592():120059. PubMed ID: 33171261 [TBL] [Abstract][Full Text] [Related]
6. Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data. Seoane-Viaño I; Pérez-Ramos T; Liu J; Januskaite P; Guerra-Baamonde E; González-Ramírez J; Vázquez-Caruncho M; Basit AW; Goyanes A J Control Release; 2024 Jan; 365():348-357. PubMed ID: 37972762 [TBL] [Abstract][Full Text] [Related]
7. Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients. Khan AA; Khuroo T; Mohamed EM; Dharani S; Canberk K; Zhang X; Sangaré LO; Kuttolamadom MA; Rice-Ficht AC; Rahman Z AAPS PharmSciTech; 2024 Sep; 25(7):217. PubMed ID: 39289236 [TBL] [Abstract][Full Text] [Related]
8. Selective Laser Sintering of a Photosensitive Drug: Impact of Processing and Formulation Parameters on Degradation, Solid State, and Quality of 3D-Printed Dosage Forms. Thakkar R; Davis DA; Williams RO; Maniruzzaman M Mol Pharm; 2021 Oct; 18(10):3894-3908. PubMed ID: 34529431 [TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo testing of 3D-Printed Amorphous Lopinavir Printlets by Selective Laser Sinitering: Improved Bioavailability of a Poorly Soluble Drug. Kayalar C; Helal N; Mohamed EM; Dharani S; Khuroo T; Kuttolamadom MA; Rahman Z; Khan MA AAPS PharmSciTech; 2024 Jan; 25(1):20. PubMed ID: 38267637 [TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of 3D-Printed Dose-Flexible Printlets of Tenofovir Disoproxil Fumarate. Kayalar C; Rahman Z; Mohamed EM; Dharani S; Khuroo T; Helal N; Kuttolamadom MA; Khan MA AAPS PharmSciTech; 2023 Aug; 24(6):171. PubMed ID: 37566167 [TBL] [Abstract][Full Text] [Related]
11. Investigating the Use of Magnetic Nanoparticles As Alternative Sintering Agents in Selective Laser Sintering (SLS) 3D Printing of Oral Tablets. Zhang Y; Thakkar R; Zhang J; Lu A; Duggal I; Pillai A; Wang J; Aghda NH; Maniruzzaman M ACS Biomater Sci Eng; 2023 Jun; 9(6):2924-2936. PubMed ID: 36744796 [TBL] [Abstract][Full Text] [Related]
12. Development of Composite, Reinforced, Highly Drug-Loaded Pharmaceutical Printlets Manufactured by Selective Laser Sintering-In Search of Relevant Excipients for Pharmaceutical 3D Printing. Kulinowski P; Malczewski P; Łaszcz M; Baran E; Milanowski B; Kuprianowicz M; Dorożyński P Materials (Basel); 2022 Mar; 15(6):. PubMed ID: 35329594 [TBL] [Abstract][Full Text] [Related]
13. Oral preparations with tunable dissolution behavior based on selective laser sintering technique. Yang Y; Xu Y; Wei S; Shan W Int J Pharm; 2021 Jan; 593():120127. PubMed ID: 33253801 [TBL] [Abstract][Full Text] [Related]
14. Pyrimethamine 3D printlets for pediatric toxoplasmosis: design, pharmacokinetics, and anti-toxoplasma activity. Rahman Z; Khuroo T; Mohamed EM; Dharani S; Kayalar C; Kuttolamadom MA; Sangaré LO; Khan MA Expert Opin Drug Deliv; 2023 Feb; 20(2):301-311. PubMed ID: 36639201 [TBL] [Abstract][Full Text] [Related]
15. Additive Manufacturing of SmartEx QD 100 Designed Oral Three-Dimensional Printlets Containing Isoniazid for Immediate Gastric Release by Selective Laser Sintering. Karanwad T; Jorvekar SB; Mandal S; Borkar RM; Banerjee S Mol Pharm; 2024 Oct; 21(10):5272-5284. PubMed ID: 39190777 [TBL] [Abstract][Full Text] [Related]
16. Selective laser sintering (SLS) 3D printing of medicines. Fina F; Goyanes A; Gaisford S; Basit AW Int J Pharm; 2017 Aug; 529(1-2):285-293. PubMed ID: 28668582 [TBL] [Abstract][Full Text] [Related]
17. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages. Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916 [TBL] [Abstract][Full Text] [Related]
18. 3D printed dispersible efavirenz tablets: A strategy for nasogastric administration in children. Funk NL; Januskaite P; Beck RCR; Basit AW; Goyanes A Int J Pharm; 2024 Jul; 660():124299. PubMed ID: 38834109 [TBL] [Abstract][Full Text] [Related]
19. Fabrication of Sustained-Release Dosages Using Powder-Based Three-Dimensional (3D) Printing Technology. Giri BR; Maniruzzaman M AAPS PharmSciTech; 2022 Nov; 24(1):4. PubMed ID: 36447026 [TBL] [Abstract][Full Text] [Related]
20. Releasing fast and slow: Non-destructive prediction of density and drug release from SLS 3D printed tablets using NIR spectroscopy. Trenfield SJ; Xu X; Goyanes A; Rowland M; Wilsdon D; Gaisford S; Basit AW Int J Pharm X; 2023 Dec; 5():100148. PubMed ID: 36590827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]